| Toward identifying the effects of the specific components of mindfulness-based stress reduction on biologic and emotional outcomes among older adults AM Gallegos, M Hoerger, NL Talbot, MS Krasner, JM Knight, JA Moynihan, ... The Journal of Alternative and Complementary Medicine 19 (10), 787-792, 2013 | 104 | 2013 |
| Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation A El‐Jawahri, YB Chen, R Brazauskas, N He, SJ Lee, JM Knight, ... Cancer 123 (10), 1828-1838, 2017 | 96 | 2017 |
| Optimism versus pessimism as predictors of physical health: A comprehensive reanalysis of dispositional optimism research. MF Scheier, JD Swanson, MA Barlow, JB Greenhouse, C Wrosch, ... American Psychologist 76 (3), 529, 2021 | 87 | 2021 |
| Low socioeconomic status, adverse gene expression profiles, and clinical outcomes in hematopoietic stem cell transplant recipients JM Knight, JD Rizzo, BR Logan, T Wang, JMG Arevalo, J Ma, SW Cole Clinical Cancer Research 22 (1), 69-78, 2016 | 79 | 2016 |
| Patient‐reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902) WA Wood, J Le‐Rademacher, KL Syrjala, H Jim, PB Jacobsen, JM Knight, ... Cancer 122 (1), 91-98, 2016 | 71 | 2016 |
| Cortisol and depressive symptoms in a population-based cohort of midlife women JM Knight, EF Avery, I Janssen, LH Powell Psychosomatic medicine 72 (9), 855-861, 2010 | 64 | 2010 |
| Psychosocial factors and hematopoietic stem cell transplantation: potential biobehavioral pathways JM Knight, JM Lyness, OJZ Sahler, JL Liesveld, JA Moynihan Psychoneuroendocrinology 38 (11), 2383-2393, 2013 | 58 | 2013 |
| Inferior access to allogeneic transplant in disadvantaged populations: a center for international blood and marrow transplant research analysis K Paulson, R Brazauskas, N Khera, N He, N Majhail, G Akpek, M Aljurf, ... Biology of Blood and Marrow Transplantation 25 (10), 2086-2090, 2019 | 49 | 2019 |
| Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial JM Knight, JD Rizzo, P Hari, MC Pasquini, KE Giles, A D’Souza, ... Blood Advances 4 (3), 467-476, 2020 | 42 | 2020 |
| Peri-transplant psychosocial factors and neutrophil recovery following hematopoietic stem cell transplantation JM Knight, JA Moynihan, JM Lyness, Y Xia, X Tu, S Messing, BC Hunter, ... PloS one 9 (6), e99778, 2014 | 41 | 2014 |
| Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis K Bona, R Brazauskas, N He, L Lehmann, H Abdel-Azim, IA Ahmed, ... Blood, The Journal of the American Society of Hematology 137 (4), 556-568, 2021 | 39 | 2021 |
| The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill JM Knight, ES Costanzo, S Singh, Z Yin, A Szabo, DS Pawar, CJ Hillard, ... Translational psychiatry 11 (1), 58, 2021 | 39 | 2021 |
| Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia K Chitta, A Paulus, TR Caulfield, S Akhtar, MKK Blake, S Ailawadhi, ... Blood cancer journal 4 (11), e260-e260, 2014 | 34 | 2014 |
| Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis KL Syrjala, SK Sutton, HSL Jim, JM Knight, WA Wood, SJ Lee, ... Cancer 123 (8), 1416-1423, 2017 | 33 | 2017 |
| Patient-reported outcomes and socioeconomic status as predictors of clinical outcomes after hematopoietic stem cell transplantation: a study from the Blood and Marrow … JM Knight, KL Syrjala, NS Majhail, M Martens, J Le-Rademacher, ... Biology of Blood and Marrow Transplantation 22 (12), 2256-2263, 2016 | 31 | 2016 |
| Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic … JM Knight, SA Kerswill, P Hari, SW Cole, BR Logan, A D’Souza, NN Shah, ... BMC cancer 18, 1-12, 2018 | 29 | 2018 |
| Interleukin (IL)-6: A good kid hanging out with bad friends (and why sauna is good for health) CL Raison, JM Knight, C Pariante Brain, behavior, and immunity 73, 1, 2018 | 25 | 2018 |
| A multidisciplinary team approach minimises prophylactic mastectomy rates DR Leff, C Ho, H Thomas, R Daniels, L Side, F Lambert, J Knight, ... European Journal of Surgical Oncology (EJSO) 41 (8), 1005-1012, 2015 | 24 | 2015 |
| Molecular correlates of socioeconomic status and clinical outcomes following hematopoietic cell transplantation for leukemia JM Knight, JD Rizzo, T Wang, N He, BR Logan, SR Spellman, SJ Lee, ... JNCI Cancer Spectrum 3 (4), pkz073, 2019 | 23 | 2019 |
| Biobehavioral pathways and cancer progression: insights for improving well-being and cancer outcomes A Chang, EK Sloan, MH Antoni, JM Knight, R Telles, SK Lutgendorf Integrative cancer therapies 21, 15347354221096081, 2022 | 22 | 2022 |
